mobileImage

MeRes100™

Sirolimus Eluting BioResorbable Vascular Scaffold System

Overview of BRS

Traditional metallic drug-eluting stents (DES) have been instrumental in restoring blood flow and supporting arterial healing. However, advancements in stent technology have introduced bioresorbable scaffolds (BRS) as a temporary support system. BRS are designed to provide structural support to the treated artery, restoring natural blood flow. Once healing is complete, these scaffolds fully dissolve, leaving the artery in its natural state without any residual foreign material. This innovation allows both physicians and patients greater flexibility for potential future interventions within the same blood vessel, supporting a long-term approach to vascular health.

Key Features

Couplets of tri-axial RO markers on both ends

High vessel conformability

Scaffold backbone PLLA 100 µm strut thickness

Drug coat of PDLLA + Sirolimus 1.25 µg/mm²

Accordian Arrow

Evolution of PCI

Accordian Arrow

The promise of BRS: Unique Chemistry

Accordian Arrow

MERES100 Angioplasty- Treatment for Coronary Artery Disease

Product Details

View
Clinical Data

Specification

Size Chart

Other Products

Evermine 50™

Evermine 50™

BioMime™

BioMime™

Metafor™

Metafor™

1 / 11

Connect with Meril

Logo
Careers
About Us
Research & Development
Our Products
Innovation
Knowledge
Meril Academy
Patient Awareness
Contact
Press & Media
Blogs
Disclaimer
Privacy Policy
Follow us on
LinkedInFacebookYouTubeInstagramInstagram